IR-Med Inc. announced the appointment of Dr. Rom Eliaz as Chief Executive Officer. Prior to his appointment as CEO, Dr. Eliaz was Founder and Managing Director at Elrom Ventures, where he also served as a Managing Director at aMoon Fund. Previously, Dr. Eliaz was Head of Merck ventures’ Fund and Bio-Incubator in Israel where he co-founded several companies in the incubator, VP of Innovative Branded Products at Teva and CEO of NasVax a publicly traded company and Immcure Therapeutics. Dr. Eliaz served as Assistant Professor at University of California San Francisco, published over 40 scientific articles and holds more than 10 scientific patents in the fields of drug targeting and delivery, gene therapy and tissue engineering.